TherapeuticsMD (TXMD) Change in Cash (2010 - 2026)

TherapeuticsMD (TXMD) has reported Change in Cash for 17 consecutive years, with $770000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 137.65% year-over-year to $770000.0; the trailing twelve-month figure through Jun 2026 stood at $3.1 million (up 272.76% YoY), and the FY2025 full-year result was $2.4 million, up 231.15% from the prior year.
• Change in Cash slipped to $770000.0 in Q2 2026 per TXMD's latest filing, from $936000.0 in the prior quarter.
• Across five years, Change in Cash topped out at $12.0 million in Q3 2022 and bottomed at -$34.7 million in Q1 2022.
• Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of $168000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Change in Cash sank 160.8% in 2022, then surged 6136.36% in 2025.
• Over 5 years, Change in Cash stood at $11.0 million in 2022, then slumped by 153.14% to -$5.8 million in 2023, then surged by 100.21% to $12000.0 in 2024, then surged by 2966.67% to $368000.0 in 2025, then surged by 109.24% to $770000.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $770000.0, $936000.0, and $368000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.